These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15548785)

  • 1. HIV-1 and HCV infections among antibody-negative blood donors.
    Begovac J; Mihaljevic I; Perrin L
    N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15548785
    [No Abstract]   [Full Text] [Related]  

  • 2. First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
    Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP
    Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 and HCV infections among antibody-negative blood donors.
    Laperche S; Pillonel J; Herve P
    N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15559959
    [No Abstract]   [Full Text] [Related]  

  • 4. First human immunodeficiency virus-1 group O infection in a European blood donor.
    Rox JM; Eis-Hübinger AM; Müller J; Vogel M; Kaiser R; Hanfland P; Däumer M
    Vox Sang; 2004 Jul; 87(1):44-5. PubMed ID: 15260822
    [No Abstract]   [Full Text] [Related]  

  • 5. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p24 antigen screening to reduce the risk of HIV transmission by seronegative bone allograft donors.
    Malhotra R; Morgan DA
    Natl Med J India; 2000; 13(4):190-2. PubMed ID: 11002686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for acute HIV infection: lessons learned.
    Stekler J; Maenza J; Stevens CE; Swenson PD; Coombs RW; Wood RW; Campbell MS; Nickle DC; Collier AC; Golden MR
    Clin Infect Dis; 2007 Feb; 44(3):459-61. PubMed ID: 17205460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology.
    Delwart E; Kuhns MC; Busch MP
    J Med Virol; 2006; 78 Suppl 1():S30-5. PubMed ID: 16622875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of HIV-1/2 dual infection using dilution analysis of type-specific antibody.
    Ariyoshi K; Cham F; Berry N; Harding E; Sabally S; N'Gom PT; Ishikawa K; Corrah T; Tedder R; Whittle H
    AIDS; 1998 Dec; 12(18):2504-5. PubMed ID: 9875593
    [No Abstract]   [Full Text] [Related]  

  • 11. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 and HCV infections among antibody-negative blood donors.
    Prince AM
    N Engl J Med; 2004 Nov; 351(21):2232-5; author reply 2232-5. PubMed ID: 15559960
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of procleix HIV/HCV RNA diagnostic assay].
    Song AJ; Zhang CT; Li XH; Li J; Wang YC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):36-8. PubMed ID: 16642216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors].
    Cavdar E; Kuştimur S; Doğruman Al F
    Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spread of HIV in one village in central China with a high prevalence rate of blood-borne AIDS.
    Zhang W; Hu D; Xi Y; Zhang M; Duan G
    Int J Infect Dis; 2006 Nov; 10(6):475-80. PubMed ID: 17049292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
    Wiedmann M; Kluwick S; Walter M; Fauchald G; Howe J; Bronold M; Zauke M
    J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA approves new HIV blood test from Roche.
    AIDS Read; 2009 Mar; 19(3):123. PubMed ID: 19338065
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
    Jarvis LM; Dow BC; Cleland A; Davidson F; Lycett C; Morris K; Webb B; Jordan A; Petrik J
    Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid amplification testing detection of an HIV-1 infection in a blood donor during the preseroconversion window period.
    Piquet Y; Ivanovic Z; Laperche S; Pillonel J; Cristol G; Jeanne M; Neau D; Fleury H; Boiron JM
    Transfus Med; 2007 Apr; 17(2):147-8. PubMed ID: 17430474
    [No Abstract]   [Full Text] [Related]  

  • 20. Seroprevalence of human immunodeficiency virus among blood donors in a rural Ethiopian hospital.
    Ramos JM; Reyes F; Tesfamariam A
    Trop Doct; 2008 Jul; 38(3):182-3. PubMed ID: 18628556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.